SPINEMarketGroup

Kyrgyzfarmatsiya, the Kyrgyz state pharmaceutical enterprise, has signed a memorandum of understanding with Turkey's Mikron Medical to supply orthopedic and spinal implants to hospitals in the country.The reason given is the interesting bit. Kyrgyzfarmatsiya says buying straight from manufacturers should cut the number of intermediaries and bring … [Read More...] about Kyrgyzstan Signs With Turkey’s Mikron. Fewer Middlemen, Lower Prices — What About Service?

Five asymptomatic spinal findings, a halted gene therapy, and a warning for anyone putting biologics into the spinal canal Regenxbio said on August 24 that the FDA had put RGX-121 back on clinical hold. The trigger was five MRI scans showing small nodules or cystic masses in patients' spines. None of those patients had symptoms. All five are doing fine. Those scans only exist because of an … [Read More...] about Regenxbio Looked. That Was the Problem.

GENEVA, Aug. 26, 2026 /PRNewswire/ -- Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PERLA® TL application (PERLA® by Spineart app) for use with the eCential® Op.n® Navigation and Robotic-Assisted Platform. Building on the previously … [Read More...] about Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.

Higgs Boson Health is a seed-stage company with a patient-facing product. The question worth asking is why a company guiding to $3.2 billion this year needed one. Globus Medical announced on August 26 that it has acquired Higgs Boson Health, a digital healthcare experience company based in Durham, North Carolina and incubated out of Duke University. No price was disclosed, and there is a reason … [Read More...] about What Globus Medical Really Bought With Higgs Boson Health

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University. With a mission to transform healthcare experience through digital innovation, … [Read More...] about Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions

BOCA RATON, Fla., Aug. 25, 2026 /PRNewswire/ -- Amplio Spine announced today that Nomen Azeem, MD, FAAPMR has joined the company as Chief Clinical Officer and Founding Chair of the Advisory Board. Dr. Azeem brings 15 years of clinical leadership in interventional spine and pain medicine, with experience in research oversight, clinical strategy, and surgical … [Read More...] about Amplio Spine™ Appoints Nomen Azeem, MD, as Chief Clinical Officer and Founding Chair of the Clinical Advisory Board

Florence, SC, Aug. 25, 2026 (GLOBE NEWSWIRE) -- DeGen Medical, Inc., a U.S.-based medical device manufacturer specializing in patient-specific spinal implants, today issued a statement regarding the new FY2027 Centers for Medicare & Medicaid Services (CMS) inpatient classification for custom-made, anatomically and virtually designed interbody fusion devices and what the change means for … [Read More...] about DeGen Medical Issues Statement on New CMS FY2027 Inpatient Classification for Patient-Specific Lumbar Fusion Procedures

PARIS, August 24, 2026 – 6:00 p.m. CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and … [Read More...] about SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

CMS released its CY2027 outpatient and ASC proposed rule on July 2. Twelve days later it released the CY2027 physician fee schedule. The comment windows close on different dates — August 31 for the outpatient rule, September 14 for the physician rule — and most of the trade coverage has handled them as two separate stories, one about facilities and one about physicians. Read together, they are one … [Read More...] about CMS 2027: Who Pays for the Implant When the Surgeon Owns the ASC?

Seventy systems, reimbursement falling around nine percent a year, and a patient population that keeps getting older. Posterior cervical fixation wins the demographic argument in spine and still gets treated as a checkbox. It sits behind lumbar interbody in most portfolio reviews, behind whatever the enabling-technology line item is that quarter, and the commercial teams that do sit down with … [Read More...] about Posterior Cervical: The Segment Everyone Serves and Nobody Owns

The Carlsbad company stretches its fixation brand north — and rents Medtronic's navigation footprint to get there. Spinal Elements has launched Overwatch PCF, a posterior cervical fixation system, and the name matters more than the launch copy suggests. Until now Overwatch has been a thoracolumbar franchise, running from the thoracic spine down through the sacrum and into the ilium, with an MIS … [Read More...] about Spinal Elements Takes Overwatch to the Neck